Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Link opens in a new tab
English
EspaƱol
Search content at University of Kentucky
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Pharmacological modulation of macrophage phenotype as a novel neuroprotective strategy following TBI.
Pauly, Jim
(PI)
Feola, David
(CoI)
Gensel, John
(CoI)
Spinal Cord and Brain Injury Research Center
Pharmacy Practice and Science
Neuroscience Research Priority Area
Overview
Fingerprint
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Neuroprotection
100%
Partial Agonist
100%
Neuroprotective Agent
100%
Azithromycin
100%
Mouse Model
50%
Anti-Inflammatory Drug
50%
Flow Cytometry
50%
Clinical Trial
50%
Encephalitis
50%
Nervous System Injury
50%
Cystic Fibrosis
50%
Spinal Cord Injury
50%
Brain Injury
50%
Nicotinic Receptor
50%
Inflammation
50%
Diseases
50%
Antimicrobial Agent
50%
Traumatic Brain Injury
50%
Rat
50%
Neuroscience
Macrophage
100%
Neuroprotective Agent
100%
Neuroprotection
33%
Azithromycin
33%
Agonist
33%
Spinal Cord Injury
16%
Nicotinic Acetylcholine Receptor
16%
Anti-Inflammatory
16%
Flow Cytometry
16%
Immunohistochemistry
16%
Cystic Fibrosis
16%
Neurotrauma
16%
Antimicrobial Agent
16%
Traumatic Brain Injury
16%
Brain Injury
16%